UK Reopens Pharma Probes After COVID-19 Delays
The United Kingdom's antitrust enforcer on Monday resumed probes of allegedly anti-competitive market allocation agreements for two drugs used to treat urinary tract infections and nausea, after the investigations largely stalled this spring...To view the full article, register now.
Already a subscriber? Click here to view full article